Etest® Ceftaroline (CPT32) WW B30. Etest® (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Published November 26, 2014 · Recall initiated: October 16, 2014
Summary
FDA records medical device Class III recall Z-0230-2015, published November 26, 2014 and initiated October 16, 2014. Recalling firm: Biomerieux; Status: Terminated; Reported quantity: 652 devices; Lot: Ref #537500, Lot #1003160540, Right Expiry date: 27-APR-2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The products have a wrong expiration date on their labeling, 5 years instead of 2 years.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux
- Distributor
- Worldwide Distribution-US (nationwide) including DC and the states of AL, AK, AR, AZ, CA, CO, DE, FL, GA, IA, IN, KY, MA, MD, MI, MO, NC, NE, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, and the countries of Australia, Austria, China, Czech Republic, France, Germany, India, Italy, Japan, Netherlands, Poland, Portugal, Switzerland, Sweden, Turkey, United Kingdom, Egypt, Pakistan, Slovenia and Uruguay.
- Lot
- Ref #537500, Lot #1003160540, Right Expiry date: 27-APR-2016
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- France
Related recalls
- FDAEtest® Ceftaroline (CPT32) US B100. Etest® (Antimicrobial Susceptibility Testing) is a quantitative techniqueNovember 26, 2014
- FDAEtest® Ceftaroline (CPT32) US B30. Etest® (Antimicrobial Susceptibility Testing) is a quantitative techniqueNovember 26, 2014
- FDAEtest® Ceftaroline (CPT32) WWB100. Etest® (Antimicrobial Susceptibility Testing) is a quantitative techniqueNovember 26, 2014
- FDAEtest® Ceftaroline (CPT32) US B30. Etest® (Antimicrobial Susceptibility Testing) is a quantitative techniqueNovember 26, 2014
- FDAADVIA Centaur BNP Assay for in vitro diagnostic use in the quantitative determination of B-type NatriureticNovember 26, 2014
- FDAFullFire Diffusing Tip Laser Probe, REF: DTP101-01, DTP201-01, DTP301-01, DTP401-01, DTP501-01. These laserNovember 26, 2014
Questions about this recall
Was Etest® Ceftaroline (CPT32) WW B30. Etest® (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria. recalled?
Yes. FDA published recall Z-0230-2015 on November 26, 2014. Reported hazard: The products have a wrong expiration date on their labeling, 5 years instead of 2 years.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit